Terms: = Head and neck cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
1448 results:
1. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
[TBL] [Abstract] [Full Text] [Related]
2. Somatic mutations of esophageal adenocarcinoma: a comparison between Black and White patients.
Lim H; Gingras MC; Zhao J; Byun J; Castro PD; Tsavachidis S; Hu J; Doddapaneni H; Han Y; Muzny DM; Gibbs RA; Amos CI; Thrift AP
Sci Rep; 2024 Apr; 14(1):8988. PubMed ID: 38637560
[TBL] [Abstract] [Full Text] [Related]
3. Treatment of esophageal adenocarcinoma in patients with a history of bariatric surgery.
Nobel T; Sewell M; Boerner T; Bains MS; Bott MJ; Gerdes H; Gray K; Nishimura M; Park BJ; Shah P; Sihag S; Jones DR; Molena D
J Gastrointest Surg; 2024 Apr; 28(4):337-342. PubMed ID: 38583881
[TBL] [Abstract] [Full Text] [Related]
4. Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
Li J; Gao X; Sun X; Li H; Wei J; Lv L; Zhu L
BMC Cancer; 2024 Apr; 24(1):416. PubMed ID: 38575885
[TBL] [Abstract] [Full Text] [Related]
5. Risk of Esophageal Adenocarcinoma After Bariatric Surgery: A Meta-Analysis of Retrospective Studies.
Zhu C; Liu W; Hu D; Peng L
Obes Surg; 2024 May; 34(5):1726-1736. PubMed ID: 38536625
[TBL] [Abstract] [Full Text] [Related]
6. Management of high risk T1 esophageal adenocarcinoma following endoscopic resection.
Leclercq P; Bisschops R; Bergman JJGHM; Pouw RE
Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101882. PubMed ID: 38522880
[TBL] [Abstract] [Full Text] [Related]
7. Esophageal adenocarcinoma heterogeneity in clinicopathology and prognosis: A single center longitudinal study of 146 cases over a 20-year period.
Huang Q; Lew E; Cheng Y; Shinagare S; Deshpande V; Gold JS; Wiener D; Weber HC
Ann Diagn Pathol; 2024 Jun; 70():152285. PubMed ID: 38518703
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
[TBL] [Abstract] [Full Text] [Related]
9. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights.
Papadakos SP; Argyrou A; Lekakis V; Arvanitakis K; Kalisperati P; Stergiou IE; Konstantinidis I; Schizas D; Koufakis T; Germanidis G; Theocharis S
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474224
[TBL] [Abstract] [Full Text] [Related]
10. Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal cancer.
Viet-Nhi NK; Minh Quan T; Cong Truc V; Anh Bich T; Hoang Nam P; Le NQK; Chen PY; Hung SH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473938
[TBL] [Abstract] [Full Text] [Related]
11. PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma.
Marcazzan S; Braz Carvalho MJ; Nguyen NT; Strangmann J; Slotta-Huspenina J; Tenditnaya A; Tschurtschenthaler M; Rieder J; Proaño-Vasco A; Ntziachristos V; Steiger K; Gorpas D; Quante M; Kossatz S
J Exp Clin Cancer Res; 2024 Feb; 43(1):53. PubMed ID: 38383387
[TBL] [Abstract] [Full Text] [Related]
12. Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma.
Ziman B; Yang Q; Zheng Y; Sheth M; Nam C; Zhao H; Zhang L; Hu B; Bhowmick NA; Sinha UK; Lin DC
Cell Death Dis; 2024 Feb; 15(2):152. PubMed ID: 38373993
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract] [Full Text] [Related]
14. Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
Seyyedsalehi MS; Boffetta P
Int J Cancer; 2024 Jun; 154(11):1920-1929. PubMed ID: 38339891
[TBL] [Abstract] [Full Text] [Related]
15. Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.
Weh KM; Howard CL; Zhang Y; Tripp BA; Clarke JL; Howell AB; Rubenstein JH; Abrams JA; Westerhoff M; Kresty LA
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38329812
[TBL] [Abstract] [Full Text] [Related]
16. cyld induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma.
Li Y; Yang C; Xie L; Shi F; Tang M; Luo X; Liu N; Hu X; Zhu Y; Bode AM; Gao Q; Zhou J; Fan J; Li X; Cao Y
Cell Death Dis; 2024 Jan; 15(1):95. PubMed ID: 38287022
[TBL] [Abstract] [Full Text] [Related]
17. Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma.
Vantanasiri K; Kamboj AK; Kisiel JB; Iyer PG
Mayo Clin Proc; 2024 Mar; 99(3):459-473. PubMed ID: 38276943
[TBL] [Abstract] [Full Text] [Related]
18. Malignant myoepithelioma of the external auditory canal - a rare case report with literature review and clinical importance of foramen of Huschke.
Mateášiková Z; Salzman R; Michálek J
World J Surg Oncol; 2024 Jan; 22(1):28. PubMed ID: 38268020
[TBL] [Abstract] [Full Text] [Related]
19. miRNA profiling of esophageal adenocarcinoma using transcriptome analysis.
Corlett R; Button C; Scheel S; Agrawal S; Rai V; Nandipati KC
Cancer Biomark; 2024; 39(3):245-264. PubMed ID: 38250763
[TBL] [Abstract] [Full Text] [Related]
20. Clinical characteristics of intradermal nevus in the external auditory canal.
Kim YH
Medicine (Baltimore); 2024 Jan; 103(3):e36765. PubMed ID: 38241581
[TBL] [Abstract] [Full Text] [Related]
[Next]
